These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 23984961

  • 1. Measles elimination: progress, challenges and implications for rubella control.
    Cutts FT, Lessler J, Metcalf CJ.
    Expert Rev Vaccines; 2013 Aug; 12(8):917-32. PubMed ID: 23984961
    [Abstract] [Full Text] [Related]

  • 2. Measles and rubella eradication in the Americas.
    Andrus JK, de Quadros CA, Solórzano CC, Periago MR, Henderson DA.
    Vaccine; 2011 Dec 30; 29 Suppl 4():D91-6. PubMed ID: 22185837
    [Abstract] [Full Text] [Related]

  • 3. Progress in measles and rubella elimination in Iran.
    Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F.
    Pediatr Infect Dis J; 2007 Dec 30; 26(12):1137-41. PubMed ID: 18043452
    [Abstract] [Full Text] [Related]

  • 4. Progress toward measles and rubella elimination in Egypt.
    El Sayed N, Kandeel N, Barakat I, Moussa I, Alexander JP, Naouri B, Reef SE.
    J Infect Dis; 2011 Jul 30; 204 Suppl 1():S318-24. PubMed ID: 21666180
    [Abstract] [Full Text] [Related]

  • 5. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008.
    Lacapère F, Magloire R, Danovaro-Holliday MC, Flannery B, Chamoulliet H, Celestin EP.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S698-705. PubMed ID: 21954269
    [Abstract] [Full Text] [Related]

  • 6. Global Measles and Rubella Laboratory Network, January 2004-June 2005.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2005 Nov 04; 54(43):1100-4. PubMed ID: 16267497
    [Abstract] [Full Text] [Related]

  • 7. The State of Measles and Rubella in the WHO European region.
    Muscat M, Ben Mamou M, Shefer A, Jankovic D, Deshevoy S, Butler R.
    Rev Esp Salud Publica; 2015 Nov 04; 89(4):345-51. PubMed ID: 26580789
    [Abstract] [Full Text] [Related]

  • 8. The end of measles and congenital rubella: an achievable dream?
    Adamo G, Sturabotti G, D'Andrea E, Baccolini V, Romano F, Iannazzo S, Marzuillo C, Villari P.
    Ann Ig; 2017 Nov 04; 29(1):1-26. PubMed ID: 28067934
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K.
    N Engl J Med; 1994 Nov 24; 331(21):1397-402. PubMed ID: 7969278
    [Abstract] [Full Text] [Related]

  • 11. Combining Global Elimination Of Measles And Rubella With Strengthening Of Health Systems In Developing Countries.
    Andrus JK, Cochi SL, Cooper LZ, Klein JD.
    Health Aff (Millwood); 2016 Feb 24; 35(2):327-33. PubMed ID: 26858388
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
    Kriss JL, Grant GB, Moss WJ, Durrheim DN, Shefer A, Rota PA, Omer SB, Masresha BG, Mulders MN, Hanson M, Linkins RW, Goodson JL.
    Vaccine; 2019 Sep 10; 37(38):5745-5753. PubMed ID: 30898393
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM, Badizadegan ND.
    Risk Anal; 2017 Jun 10; 37(6):1109-1131. PubMed ID: 28561947
    [Abstract] [Full Text] [Related]

  • 17. Surveillance and vaccination coverage of measles and rubella in Northern Italy.
    Amendola A, Bubba L, Piralla A, Binda S, Zanetti A, Pariani E, Ranghiero A, Premoli M, Pellegrinelli L, Coppola L, Gramegna M, Baldanti F, Zanetti A.
    Hum Vaccin Immunother; 2015 Jun 10; 11(1):206-13. PubMed ID: 25483537
    [Abstract] [Full Text] [Related]

  • 18. Towards elimination of measles and rubella in Italy: Progress and challenges.
    Adamo G, Baccolini V, Massimi A, Barbato D, Cocchiara R, Di Paolo C, Mele A, Cianfanelli S, Angelozzi A, Castellani F, Salerno C, Isonne C, Bella A, Filia A, Del Manso M, Baggieri M, Nicoletti L, Magurano F, Iannazzo S, Marzuillo C, Villari P.
    PLoS One; 2019 Jun 10; 14(12):e0226513. PubMed ID: 31841530
    [Abstract] [Full Text] [Related]

  • 19. Measles and Rubella Global Strategic Plan 2012-2020 midterm review report: Background and summary.
    Orenstein WA, Cairns L, Hinman A, Nkowane B, Olivé JM, Reingold AL.
    Vaccine; 2018 Jan 11; 36 Suppl 1():A35-A42. PubMed ID: 29307368
    [Abstract] [Full Text] [Related]

  • 20. Progress toward measles elimination--European Region, 2005--2008.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Feb 20; 58(6):142-5. PubMed ID: 19229166
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.